Epirubicin in the treatment of malignant mesothelioma: a phase II cooperative study. The North-Eastern Italian Oncology Group (GOCCNE)--Mesothelioma Committee.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples